Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer

Autor: Hao Zeng, Yaojing Yang, Pengfei Shen, Guangxi Sun, Xingming Zhang, Jing Gong, Jiang-Dong Liu, Haojun Gui, Xueqin Chen, Ni Chen, Jinge Zhao, Kunpeng Shu
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Adult
Male
Oncology
China
medicine.medical_specialty
Pathology
overall survival
Urology
Bone Neoplasms
Kaplan-Meier Estimate
castration-resistance prostate cancer-free survival
International Society of Urological Pathology grading system
metastasis
prostate cancer
lcsh:RC870-923
Disease-Free Survival
Metastasis
Prostate cancer
Predictive Value of Tests
Prostate
Internal medicine
medicine
Humans
Neoplasm Metastasis
Aged
Aged
80 and over

Gleason grading system
Univariate analysis
Receiver operating characteristic
Proportional hazards model
business.industry
Prostatic Neoplasms
Bone metastasis
General Medicine
Middle Aged
Prognosis
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
Survival Analysis
Prostatic Neoplasms
Castration-Resistant

Treatment Outcome
medicine.anatomical_structure
Original Article
Neoplasm Grading
business
Zdroj: Asian Journal of Andrology, Vol 19, Iss 5, Pp 573-578 (2017)
Asian Journal of Andrology
ISSN: 1745-7262
Popis: We compared the predictive ability of the 2014 and 2005 Gleason grading systems in 568 patients initially diagnosed with metastatic prostate cancer (PCa). Outcomes included the duration of castration-resistant prostate cancer-free survival (CFS) and overall survival (OS). Univariate analyses and log-rank tests were used to identify prognosis indicators and assess univariable differences in CFS and OS in Gleason score (GS) groups. Cox proportional hazards and area under the curves of receiver operator characteristics methods were used to evaluate the predictive efficacy of the 2005 and 2014 ISUP grading systems. Univariate analyses showed that the 2005 and 2014 grading systems were prognosticators for CFS and OS; both systems could distinguish the clinical outcome of patients with GS 6, GS 7, and GS 8-10. Using the 2014 criteria, no statistical differences in patient survival were observed between GS 3 + 4 and GS 4 + 3 or GS 8 and GS 9-10. The predictive ability of the 2014 and 2005 grading systems was comparable for CFS and OS (P = 0.321). However, the 2014 grading system did not exhibit superior predictive efficacy in patients initially diagnosed with PCa and bone metastasis; trials using larger cohorts are required to confirm its predictive value. To the best of our knowledge, ours is the first study to compare the 2005 and 2014 grading systems in initially diagnosed PCa with bone metastasis. At present, we recommend that both systems should be used to predict the prognosis of patients with metastatic PCa.
Databáze: OpenAIRE